Cargando…
Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know
Melanoma of the ocular region (ocular melanoma) comprises about 5% of all patients with melanoma and covers posterior uveal melanoma, iris melanoma, and conjunctival melanoma. The risk of metastasis is much higher in patients with ocular melanoma compared to a primary melanoma of the skin. The subty...
Autores principales: | Bol, Kalijn Fredrike, Donia, Marco, Heegaard, Steffen, Kiilgaard, Jens Folke, Svane, Inge Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432371/ https://www.ncbi.nlm.nih.gov/pubmed/32718045 http://dx.doi.org/10.3390/ijms21155231 |
Ejemplares similares
-
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
por: Bol, Kalijn Fredrike, et al.
Publicado: (2019) -
Microsatellite instability: a review of what the oncologist should know
por: Li, Kai, et al.
Publicado: (2020) -
No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells
por: Faber, Carsten, et al.
Publicado: (2019) -
Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70‐year nationwide cohort
por: Smidt‐Nielsen, Isabel, et al.
Publicado: (2021) -
Risk of New Primary Cancer in Patients with Posterior Uveal Melanoma: A National Cohort Study
por: Bagger, Mette, et al.
Publicado: (2022)